PARIS (Reuters) – French healthcare company Sanofi said on Wednesday that it had seen positive results in the first study of a high-dose influenza vaccine delivered at the same time as a COVID-19 mRNA booster. Sanofi said the interim results…
Read More
2019 novel coronavirus is genetically different to SARS and should be considered a new human-infecting coronavirus
A new genetic analysis of 10 genome sequences of novel coronavirus (2019-nCoV) from nine patients in Wuhan finds that the virus is most closely related to two bat-derived SARS-like coronaviruses, according to a study published in The Lancet. The authors…
Read More
Modelling study estimates spread of 2019 novel coronavirus
New modelling research, published in The Lancet, estimates that up to 75,800 individuals in the Chinese city of Wuhan may have been infected with 2019 novel coronavirus (2019-nCoV) as of January 25, 2020. Authors caution that given the lack of…
Read More